AstraZeneca
dual primary | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
12 of 42
Similar slides by AstraZeneca
See diffirences between slides (animation)
Investor Event
December 2022
overall survival data at maturity | AstraZeneca
Investor Event
December 2022
investigator assessed in the non altered population including unknown unknown | AstraZeneca
Investor Event
December 2022
dual primary months | AstraZeneca
Related slides by other companies
Kymera
Investor Day
December 2021
achieved degradation in monocytes at flow i | Kymera
argenx SE
Results
May 2022
primary met | argenx SE
Aeglea BioTherapeutics
Investor Presentation
April 2023
peace phase trial marked and sustained reduction in plasma arginine | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
March 2023
peace phase trial marked and sustained reduction in plasma arginine | Aeglea BioTherapeutics
Other recent decks by AstraZeneca
See all presentations (27 decks)
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io